The sensitivities of the Xpert MTB/RIF test and an in-house IS6110-based real-time PCR using TaqMan probes (IS6110-TaqMan assay) for the detection of Mycobacterium tuberculosis complex (MTBC) DNA were compared by use of 117 clinical specimens (97 culture positive and 20 culture negative for MTBC) that were frozen in sediment. The 97 clinical specimens included 60 respiratory and 37 nonrespiratory specimens distributed into 36 smear-positive and 61 smear-negative specimens. Among the 97 culture-positive specimens, 4 had rifampin-resistant isolates. Both methods were highly specific and exhibited excellent sensitivity (100%) with smear-positive specimens. The sensitivity of the Xpert MTB/RIF test with the whole smear-negative specimens was more reduced than that of the IS6110-TaqMan assay (48 versus 69%, P ؍ 0.005). Both methods exhibited similar sensitivities with smear-negative respiratory specimens, but the Xpert MTB/RIF test had lower sensitivity with smear-negative nonrespiratory specimens than the IS6110-TaqMan assay (37 versus 71%, P ؍ 0.013). Finally, the sensitivities of the Xpert MTB/RIF test and the IS6110-TaqMan assay were 79% and 84%, respectively, with respiratory specimens and 53% and 78%, respectively (P ؍ 0.013), with nonrespiratory specimens. The Xpert MTB/RIF test correctly detected the rifampin resistance in smear-positive specimens but not in the one smear-negative specimen. The Xpert MTB/RIF test is a simple rapid method well adapted to a routine laboratory that appeared to be as sensitive as the IS6110-TaqMan assay with respiratory specimens but less sensitive with paucibacillary specimens, such as smear-negative nonrespiratory specimens.Nucleic acid amplification assays (NAAAs) are commonly used in routine laboratories from industrialized countries for quick and specific detection of Mycobacterium tuberculosis complex (MTBC) in clinical specimens. Over the years, a significant improvement of PCR technologies has been achieved with the development of real-time PCR testing platforms. The main advantages of real-time PCR are a shortened turnaround time; automation of the procedure, which reduces hands-on time; and a decrease in the risk of cross-contamination (6). Recently, the GeneXpert system (Cepheid, Sunnyvale, CA), a real-time PCR that simultaneously detects both MTBC and rifampin resistance, was developed (1, 3, 9). In contrast to some real-time PCR instruments, the Xpert MTB/RIF is an on-demand assay described as a simple method that can be performed by personnel with minimal training and can provide results within 2 h (1, 3, 9). Recent studies (3, 9, 15, 16) reported a high sensitivity and specificity of the Xpert MTB/RIF test with respiratory specimens collected from patients living in countries with a high and a low prevalence of tuberculosis (TB). The detection of rifampin resistance, as a surrogate for multidrug-resistant TB (MDR-TB), directly from smear-positive respiratory specimens from patients having a high risk of MDR-TB has recently been recommended by the World Health...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.